House passes bill to create health agency focused on biomedical innovation

The House passed on Wednesday to create a new biomedical innovation in the search for biomedical innovation.

The legislation, dubbed the Advanced Research Projects Agency – Health Act, passed in a 336-85 vote, with all “no” votes coming from Republicans. Six Republicans and two Democrats did not vote.

The bill calls for establishing the Advanced Research Projects Agency-Health (ARPA-H) within the Department of Health and Human Services.

The goal of the agency, according to the legislation, is to “foster the development of new breakthrough capabilities, technologies, systems, and platforms to accelerate innovations in health and medicine that are not met by Federal programs or private entities.”

The bill also says the new agency would work to expand “transforming health technologies,” which lawmakers say would dramatically change the act of detecting, diagnosing, mitigating, preventing, treating and curing significant diseases and medical conditions.

To achieve these goals, the bill would direct the health board to discover and promote new scientific techniques to help with early detection and intervention of diseases.

Rep. Diana DeGette (D-Colo.) On the House floor said the new agency will help “make the impossible possible.”

“What we need more now is an all-hands-on approach to end these illnesses, and that’s exactly why this legislation was developed,” DeGette said during a debate on the legislation.

“[I]t will create a new advanced research agency, ARPA-H, which will bring together the federal government’s seemingly unlimited resources to make the impossible possible, ”she added.

Rep. Fred Upton (R-Mich.) Said the new program will be “game-changing health research,” likening it to the Defense Advanced Research Projects Agency, or DARPA, which is the agency within the Defense Department that oversees research and development programs.

“Like DARPA, this entity is gonna be focused on producing research on things that can be too risky for the private sector. It’s gonna move at a faster pace than the current structure, ”Upton said.

“There may be a high failure rate, but its successes are going to have the potential to be absolutely ground-breaking, answering the prayers of millions,” he added.

The Biden administration threw its support behind the bill earlier this week. In its statement of administrative policy, the Office of Management and Budget (OMB) stated that the bill “will provide a novel pathway to catalyze transformative health breakthroughs that cannot easily be achieved through traditional research or commercial activity.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker